Open-label Study of Safety and Tolerability of Memantine in Children With Autism
Public ClinicalTrials.gov record NCT01999894. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the long-term safety and tolerability of memantine in the treatment of autism in pediatric patients.
Study identification
- NCT ID
- NCT01999894
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 102 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2009
- Primary completion
- Jan 31, 2013
- Completion
- Jan 31, 2013
- Last update posted
- Mar 17, 2014
2009 – 2013
United States locations
- U.S. sites
- 19
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 005 | Phoenix | Arizona | 85006 | — |
| Forest Investigative Site 003 | Sacramento | California | 95817 | — |
| Forest Investigative Site 021 | San Francisco | California | 94143 | — |
| Forest Investigative Site 026 | Santa Ana | California | 92701 | — |
| Forest Investigative Site 020 | Santa Ana | California | 92705 | — |
| Forest Investigative Site 002 | Stanford | California | 94305 | — |
| Forest Investigative Site 024 | Jacksonville Beach | Florida | 32250 | — |
| Forest Investigative Site 007 | St. Petersburg | Florida | 33701 | — |
| Forest Investigative Site 014 | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative Site 023 | Naperville | Illinois | 60563 | — |
| Forest Investigative Site 010 | Indianapolis | Indiana | 46202 | — |
| Forest Investigative Site 025 | Cambridge | Massachusetts | 02138 | — |
| Forest Investigative Site 011 | Toms River | New Jersey | 08755 | — |
| Forest Investigative Site 006 | Voorhees Township | New Jersey | 08043 | — |
| Forest Investigative Site 017 | Manhasset | New York | 10030 | — |
| Forest Investigative Site 013 | Cleveland | Ohio | 44106 | — |
| Forest Investigative Site 015 | Cleveland | Ohio | 44106 | — |
| Forest Investigative Site 001 | Columbus | Ohio | 43210 | — |
| Forest Investigative Site 019 | Oklahoma City | Oklahoma | 73116 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01999894, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2014 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01999894 live on ClinicalTrials.gov.